JPRN-UMIN000002556
Completed
未知
Monitoring of neuromuscular block caused by rocuronium at the orbicularis oris, corrugator supercilli, or adductor pollicis muscle - Neuromuscular monitoring at the orbicularis oris, corrugator supercilli, or adductor pollicis muscle
Tsujinaka Hospital Kashiwanoha0 sites36 target enrollmentSeptember 29, 2009
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Abdominal diseases which need surgical procedure under general anesthesia
- Sponsor
- Tsujinaka Hospital Kashiwanoha
- Enrollment
- 36
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Unhealthy patients with American Society of Anesthesiologists (ASA)physical status of more than 3\. Patients with neuromuscular, hepatic, renal, cardiac, metabolic disease. Patients taking drugs to affect with the action of neuromuscular relaxant.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
Monitoring of neuromuscular blockade during general anaesthesia2024-517831-28-00Pirkanmaan hyvinvointialue120
Not yet recruiting
Not Applicable
A study to evaluate the rate of muscle weakness remaining after cancer surgeries.Health Condition 1: O- Medical and SurgicalHealth Condition 2: C00-D49- NeoplasmsCTRI/2024/03/063717Tata Memorial Hospital
Completed
Not Applicable
Rocuronium-induced neuromuscular block and reversibility with sugammadex at the corrugator supercilii and adductor pollicis musclesSurgical patients requiring general anesthesiaJPRN-UMIN000010240ihon University of Medicine Department of Anesthesiology40
Completed
Not Applicable
Occurance of residual neuromuscular blockade in patients received general anesthesiaDiseases which need operation under general anesthesiaJPRN-UMIN0000026394 University investigation of neuromuscular blockade25
Not yet recruiting
Not Applicable
Reversal of rocuronium induced neuromuscular block by sugammadex for electroconvulsive therapy; crossover designed dose response studyPsychiatric diseaseJPRN-UMIN000007254Tokyo Women's Medical University Hospital20